Efficacy Study of Vaginal Mesh for Prolapse

Medstar Health Research Institute65 enrolled

Overview

The primary aim of this double-blind, randomized clinical trial (RCT) is to test the hypothesis that the addition of a standardized technique of interpositional synthetic polypropylene mesh placement improves the one-year outcome of vaginal reconstructive surgery for pelvic organ prolapse compared to traditional vaginal reconstructive surgery without mesh.

Minimally invasive surgical procedures using mesh have rapidly developed in the field of pelvic floor reconstruction. Unfortunately, safety and efficacy data have lagged behind the technical advancements. No randomized controlled trials of different vaginal apical suspension procedures have been reported. The use of synthetic vaginal mesh has evolved due to the 20-30% recurrence rate for conventional pelvic reconstructive surgeries. This trial will examine synthetic monofilament polypropylene mesh use in vaginal reconstructive surgery for vaginal Stage II-IV prolapse.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

Conditions

Pelvic Organ Prolapse Uterine Prolapse Vaginal Prolapse Cystocele Rectocele

Interventions

synthetic monofilament polypropylene meshDEVICE

Vaginal prolapse repair with mesh

Eligibility

Sex: FEMALEMin age: 21 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Woman \> 21 yrs * Stage II-IV vaginal prolapse * Desires vaginal reconstructive surgery * Able to complete study questionnaires and assessments * Uterus \< 12 weeks size * Available for 12 months follow-up Exclusion Criteria: * Medical contraindications, e.g. current urinary tract, vaginal or pelvic infection, history of pelvic irradiation, history of lower urinary tract malignancy, chronic steroid use or a compromised immune system. * Current intermittent catheterization. * Pregnancy or desire for future fertility. * Presence of an adnexal mass. * Shortened vagina or other known Mullerian anomaly (e.g. uterine didelphys). * Other laparoscopic or abdominal/pelvic surgery in the past 3 months. * Known neurologic or medical condition affecting bladder function, e.g. Multiple Sclerosis, spinal cord injury. * Need for concomitant surgery requiring an abdominal incision. * \< 12 months post-partum. * Non-english speaking

Locations (1)

Washington Hospital Center

Washington D.C., District of Columbia, United States

Outcomes

Primary Outcomes

Number of Participants With Anatomic Cure at 3 Years

3 different measures for Anatomic cure using POPQ measurements: 1. POP-Q at Stage I or less\* (POP-Q points Ba, Bp or C -1 or less); 2. no prolapse beyond the hymen (Ba, Bp or C 0 or less); 3. no prolapse beyond the hymen (Ba, Bp 0 or less) with adequate apical support above the midvagina (C to TVL/2 or less) No bulge symptoms using Pelvic Floor Distress Inventory, PFDI question 3; do you see or feel a bulge in the vaginal area with response of no. Patient Satisfaction using Patient Global Impression of Improvement with response of very much better or much better

Time frame: 3 year

Secondary Outcomes

Bothersome Dyspareunia

Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire question 5 response of usually or always and tracked resolution, persistence, de novo dyspareunia

Time frame: 3 year

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.